Topical corticosteroid phobia in atopic dermatitis: a systematic review AW Li, ES Yin, RJ Antaya JAMA dermatology 153 (10), 1036-1042, 2017 | 182 | 2017 |
Speed of adoption of immune checkpoint inhibitors of programmed cell death 1 protein and comparison of patient ages in clinical practice vs pivotal clinical trials JM O’Connor, KL Fessele, J Steiner, K Seidl-Rathkopf, KR Carson, ... JAMA oncology 4 (8), e180798-e180798, 2018 | 103 | 2018 |
Second-hit, postzygotic PMVK and MVD mutations in linear porokeratosis L Atzmony, HM Khan, YH Lim, AS Paller, JL Levinsohn, KE Holland, ... JAMA dermatology 155 (5), 548-555, 2019 | 61 | 2019 |
Nivolumab-associated vitiligo-like depigmentation in a patient with acute myeloid leukemia: A novel finding ES Yin, MB Totonchy, JS Leventhal JAAD Case Reports 3 (2), 90-92, 2017 | 53 | 2017 |
Fusaric acid induces a notochord malformation in zebrafish via copper chelation ES Yin, M Rakhmankulova, K Kucera, JG de Sena Filho, CE Portero, ... Biometals 28, 783-789, 2015 | 38 | 2015 |
The skin as a window to the blood: cutaneous manifestations of myeloid malignancies AW Li, ES Yin, M Stahl, TK Kim, G Panse, AM Zeidan, JS Leventhal Blood Reviews 31 (6), 370-388, 2017 | 37 | 2017 |
Biodegradable bioadhesive nanoparticle incorporation of broad‐spectrum organic sunscreen agents HW Suh, J Lewis, L Fong, JY Ramseier, K Carlson, ZH Peng, ES Yin, ... Bioengineering & Translational Medicine 4 (1), 129-140, 2019 | 29 | 2019 |
Nonsurgical treatment of skin cancer with local delivery of bioadhesive nanoparticles JK Hu, HW Suh, M Qureshi, JM Lewis, S Yaqoob, ZM Moscato, S Griff, ... Proceedings of the National Academy of Sciences 118 (7), e2020575118, 2021 | 26 | 2021 |
Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in Merkel cell carcinoma: a surveillance, epidemiology, and … HH Ezaldein, A Ventura, NP DeRuyter, ES Yin, A Giunta Oncoscience 4 (7-8), 106, 2017 | 23 | 2017 |
Organizational culture in cardiovascular care in Chinese hospitals: a descriptive cross-sectional study ES Yin, NS Downing, X Li, SJ Singer, LA Curry, J Li, HM Krumholz, ... BMC Health Services Research 15, 1-10, 2015 | 10 | 2015 |
Transparency and dermatologic device approval by the US Food and Drug Administration HH Ezaldein, JF Scott, ES Yin, A Ventura, NP DeRuyter, DJ Leffell JAMA dermatology 154 (3), 273-280, 2018 | 6 | 2018 |
Speed of adoption of immune checkpoint inhibitors of programmed cell death 1 protein and comparison of patient ages in clinical practice vs pivotal clinical trials. JAMA Oncol … JM O’Connor, KL Fessele, J Steiner, K Seidl-Rathkopf, KR Carson, ... | 6 | 2018 |
A 54-year-old woman with arthritis and discoloration of the hands, ears, and sclerae. ES Yin, JD Knispel, JM McNiff, JS Leventhal International Journal of Dermatology 56 (7), 2017 | 2 | 2017 |
Adoption of immunotherapy into real-world practice: Insights from the use of checkpoint inhibitors. J O'Connor, K Seidl-Rathkopf, P You, NC Nussbaum, AZ Torres, ... Journal of Clinical Oncology 35 (15_suppl), e14583-e14583, 2017 | 2 | 2017 |
Racial disparities in the use of programmed death-1 checkpoint inhibitors. J O'Connor, K Seidl-Rathkopf, AZ Torres, P You, NC Nussbaum, ... Journal of Clinical Oncology 35 (15_suppl), 3068-3068, 2017 | 2 | 2017 |
666 Biodegradable poly (lactic acid)-hyperbranched polyglycerol nanoparticle encapsulated drug delivery for skin cancer treatment ES Yin, J Lewis, H Suh, WM Saltzman, M Girardi Journal of Investigative Dermatology 137 (5), S115, 2017 | 1 | 2017 |
390 Second-hit, post-zygotic PMVKand MVD mutations cause linear porokeratosis L Atzmony, H Khan, YH Lim, AS Paller, J Levinsohn, KE Holland, ... Journal of Investigative Dermatology 139 (5), S67, 2019 | | 2019 |
1070 Biodegradable bioadhesive nanoparticle delivery of camptothecin for the treatment of PDV squamous cell carcinoma AK Lee, H Suh, E Yin, J Lewis, W Saltzman, M Girardi Journal of Investigative Dermatology 138 (5), S181, 2018 | | 2018 |
Violaceous Plaques and Papulonodules on the Umbilicus JS Leventhal, E Yin, S Imaeda Cutis 101 (3), E11-E13, 2018 | | 2018 |
Biodegradable Nanoparticles In The Treatment Of Cutaneous Malignancy ES Yin | | 2018 |